ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
Patent Owner
Stats
- 30 US PATENTS IN FORCE
- 3 US APPLICATIONS PENDING
- Aug 16, 2016 most recent publication
Details
- 30 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 419 Total Citation Count
- Jul 16, 1997 Earliest Filing
- 55 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2015/0374,288 SYSTEM AND METHOD FOR DETECTING AN ENDO-URETHRAL DEVICE FOR AN ARTIFICIAL SPHINCTER THAT IS IMPLANTABLE IN AN ANIMAL OR HUMAN BODYJan 31, 14Dec 31, 15[A61F, A61B]
2012/0225,947 RETINAL NEUROPROTECTION BY ION CHANNEL BLOCKERS REGULATED BY THE SUR SUBUNITSep 23, 10Sep 06, 12[A61K, A61P]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9416392 Diagnosis of bacterial meningitis based on the measure of ROS production in a sample of cerebrospinal fluidJul 26, 11Aug 16, 16[C12Q, G01N]
9340819 Method for detecting the presence of carbapenemase-producing bacteria in a sampleJun 21, 12May 17, 16[C12Q]
9297046 TET2 as a new diagnostic and pronostic marker in hematopoietic neoplasmsMar 21, 12Mar 29, 16[C12Q]
9272054 Agents for the molecular imaging of serine-protease in human pathologiesDec 05, 11Mar 01, 16[A61K, A61M]
9233144 Tyrosine kinase receptor TYRO3 as a therapeutic target in the treatment of cancerSep 18, 09Jan 12, 16[A61K, C12Q, C12N, G01N, C07K]
9198949 Method and pharmaceutical composition for use in the treatment of cancerJun 06, 13Dec 01, 15[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0136,103 Pharmaceutical Composition in the Form of Granules for the Treatment of Metabolic Disorders in ChildrenAbandonedJun 26, 14May 19, 16[A61K]
2015/0323,550 METHOD FOR THE DIAGNOSIS OF SYSTEMIC SCLERODERMA OR OF PULMONARY ARTERIAL HYPERTENSIONAbandonedApr 14, 15Nov 12, 15[G01N]
2015/0276,760 Method for Screening a Compound Capable of Inhibiting the Notch1 Transcriptional ActivityAbandonedOct 04, 12Oct 01, 15[A61K, G01N]
2015/0247,196 IN VITRO GENETIC DIAGNOSTIC OF INHERITED NEUROMUSCULAR DISORDERSAbandonedSep 06, 13Sep 03, 15[C12Q]
2015/0197,574 USE OF TRANSFERRIN RECEPTOR ANTAGONIST FOR THE TREATMENT OF THALASSEMIAAbandonedAug 02, 13Jul 16, 15[C07K]
2015/0184,155 METHODS FOR PREVENTING AND TREATING CHRONIC KIDNEY DISEASE (CKD)AbandonedJul 18, 13Jul 02, 15[C12N, C07K]
2015/0140,043 IMMUNOMODULATORY METHODS USING NOTCH AGONISTSAbandonedMay 07, 13May 21, 15[A61K, C12Q, G01N]
2015/0126,573 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTION OR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASEAbandonedMay 07, 13May 07, 15[A61K, G01N]
2015/0105,329 Methods and Pharmaceutical Compositions for Prevention or Treatment of Ischemia Related Organ DamageAbandonedMar 26, 13Apr 16, 15[A61K]
2015/0031,569 Mutations of the GPR179 Gene in Congenital Stationary Night BlindnessAbandonedJan 23, 13Jan 29, 15[C12Q, G01N, C07K]
2014/0371,082 PROCESS AND APPARATUS FOR QUANTIFYING NUCLEIC ACID IN A SAMPLEAbandonedJul 02, 12Dec 18, 14[C12Q]
2014/0335,119 POLYPEPTIDE DERIVED FROM gp41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUALAbandonedMay 23, 14Nov 13, 14[A61K, C12N, C07K]
2014/0286,967 Methods for the Treatment and the Prognostic Assessment of Malignant Pleural MesotheliomaAbandonedJun 06, 14Sep 25, 14[C07K]
2014/0199,379 COMPOSITIONS HAVING MEANS FOR TARGETING AT LEAST ONE ANTIGEN TO DENDRITIC CELLSAbandonedJul 23, 12Jul 17, 14[A61K]
2014/0018,643 SELF-CONTAINED SYSTEM SUITABLE FOR BEING INSERTED INTO AN ANATOMICAL CAVITYAbandonedJan 20, 12Jan 16, 14[A61B]
2013/0331,291 METHOD FOR PREDICTING THE OUTCOME OF COLON CANCER BY ANALYSING MIRNA EXPRESSIONAbandonedDec 01, 11Dec 12, 13[C12Q]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.